Dr Jenny Wells

Name:	Dr Jenny Wells
Affiliation:	Cancer Research UK Cambridge Research Institute
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	Fri Sep 07 14:55:31 +0000 2007

Public lists managed by Dr Jenny Wells

Talks given by Dr Jenny Wells

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Dr Jenny Wells

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Dr Jenny Wells actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Stem cells
• Basics of the Cell Cycle
• Oncogenes
• Title to be confirmed
• Control of DNA Replication
• Tumour natural history, structure and nomenclature (lecture/demonstration)
• Gain-of-function JAK2 mutations in the human myeloproliferative disorders
• Title to be confirmed
• Overview of cancer theoretical framework
• Proteins that license DNA replication (Laskey) Clinical exploitation of proteins that license DNA replication (Coleman)
• Viruses as gene therapy vectors
• Title to be confirmed
• Functional breast cancer genomics: from basic biology to clinical application
• Prospective translational research in clinical trials
• Title to be confirmed
• Models to study breast cancer, invasion and the instability of the differentiated state
• Centrosome cycle, cell division and chromosome segregation
• Molecular genetics of MALT lymphoma: application in diagnosis and prognosis (Prof Ming Du), tbc (Prof Robert Marcus)
• Barrett's oesophagus as model for early cancer detection/treatment
• "Targeting the Met receptor for cancer therapy" (Ermanno Gherardi) and "Preclinical efforts in Pancreatic Cancer" (Dave Tuveson)
• Tissue-specification and transcriptional regulatory circuitry
• Clinical lectures on prostate, bladder, renal and testis cancer
• Clinical drug resistance in epithelial cancer
• Oncogenes and Tumor Suppressors: The Good, The Bad and The Ugly
• Nuclear Receptors and their roles in transcription and breast cancer
• Role of NCOA4 protein in controlling DNA replication
• Assessing responses to cancer therapy using molecular imaging magnetic resonance methods
• Targeting RET kinase activity as a novel therapeutic strategy for medullary thyroid carcinoma
• Radiotherapy in management of cancer
• Introduction to chemotherapy: role of Kaplan Meier curves in clinical cancer research
• Chromatin modifying enzymes and their involvement in cancer
• Developments in radiotherapy: new treatments for today and tomorrow
• Human Sarcomas - Prostate and Bladder Cancers
• Genetic association studies to find common disease susceptibility alleles
• Exploiting senescence and anoikis in function-based oncogenomic screens
• A tool of developmental biology for understanding tumorigenesis
• Towards a fuller understanding of inherited susceptibility to colorectal cancer
• CANCELLED
• Novel mechanisms of clinical drug resistance in ovarian cancer
• Intestinal cancer models and stem cell biology
• Molecular heterogeneity of breast cancer - biological and clinical implications
• Proteinases and cancer
• Title to be confirmed
• Lymphocyte Development
• Why computational biology is useful in the cancer world
• Experimental cancer medicine at the Dana Farber Cancer Institute
• Stem cells and cancer
• Germline genetic predictors of prognosis in breast cancer
• Ubiquitin/proteasome mediated protein degradation
• Dimethyl sulfoxide to vorinostat-targeted histone deacetylase inhibitor – mechanisms of action as an anti-cancer drug
• Nuclear Receptors and their roles in transcription and breast cancer
• RNAi Functional Analysis of Drug Resistance Pathways
• Breast Cancer
• Title to be confirmed
• Title to be confirmed
• Genomic Imprinting and Cancer